156 related articles for article (PubMed ID: 2711552)
1. Ileal conduit in era of systemic chemotherapy.
Wishnow KI; Johnson DE; Dmochowski R; Chong C
Urology; 1989 May; 33(5):358-60. PubMed ID: 2711552
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy and cystectomy in patients with bladder carcinoma.
Herr HW
Eur Urol; 1988; 14 Suppl 1():41. PubMed ID: 3181241
[No Abstract] [Full Text] [Related]
3. Preliminary results in invasive bladder cancer with transurethral resection, neoadjuvant chemotherapy and combined pelvic irradiation plus cisplatin chemotherapy.
Prout GR; Shipley WU; Kaufman DS; Heney NM; Griffin PP; Althausen AF; Bassil B; Nocks BN; Parkhurst EC; Young HH
J Urol; 1990 Nov; 144(5):1128-34; discussion 1134-6. PubMed ID: 2122007
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant M-VAC chemotherapy and partial cystectomy for treatment of locally invasive transitional cell carcinoma of the bladder.
Simon SD; Srougi M
Prog Clin Biol Res; 1990; 353():169-74. PubMed ID: 2217415
[No Abstract] [Full Text] [Related]
5. Laparoscopic radical cystectomy with ileal conduit urinary diversion.
Sorcini A; Tuerk I
Urol Oncol; 2004; 22(2):149-52. PubMed ID: 15082015
[TBL] [Abstract][Full Text] [Related]
6. [Penile metastasis from bladder cancer. A case report].
Gentile V; Mariotti G; Fattore F; Cardi A; Di Silverio F
Minerva Urol Nefrol; 2002 Jun; 54(2):129-30. PubMed ID: 12070461
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy in deeply invasive bladder cancer: the Italian experience. The Lombard Urologists.
Semin Urol; 1990 Aug; 8(3):205-9. PubMed ID: 2204982
[No Abstract] [Full Text] [Related]
8. [Pelvic recurrence of urothelial tumor, after radical cysto-prostatectomy with orthotopic neo-bladder].
Pascual Regueiro D; Mallén Mateo E; Trívez Boned MA; García García MA; Gil Sanz MJ; Rioja Sanz LA
Actas Urol Esp; 2003 Sep; 27(8):629-32. PubMed ID: 14587238
[TBL] [Abstract][Full Text] [Related]
9. An improved ileal conduit surgery for bladder cancer with fewer complications.
Li Z; Liu Z; Yao K; Qin Z; Han H; Li Y; Dong P; Ye Y; Wang Y; Wu Z; Zhang Z; Zhou F
Cancer Commun (Lond); 2019 Apr; 39(1):19. PubMed ID: 30999948
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.
Freiha F; Reese J; Torti FM
J Urol; 1996 Feb; 155(2):495-9; discussion 499-500. PubMed ID: 8558644
[TBL] [Abstract][Full Text] [Related]
11. Southwest Oncology Group Study 8710: trial of cystectomy alone versus neo-adjuvant M-VAC and cystectomy in patients with locally advanced bladder cancer (Intergroup Trial 0080).
Crawford ED; Natale RB; Burton H
Prog Clin Biol Res; 1990; 353():111-3. PubMed ID: 2217407
[No Abstract] [Full Text] [Related]
12. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
Maarouf AM; Khalil S; Salem EA; ElAdl M; Nawar N; Zaiton F
BJU Int; 2011 May; 107(10):1605-10. PubMed ID: 20825396
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate, vinblastine, doxorubicin and cisplatin followed by radiotherapy or surgery for muscle invasive bladder cancer: the University of Chicago experience.
Vogelzang NJ; Moormeier JA; Awan AM; Weichselbaum RR; Farah R; Straus FH; Schoenberg HW; Chodak GW
J Urol; 1993 Apr; 149(4):753-7. PubMed ID: 8455237
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
15. Invasive bladder carcinoma: preliminary report of selective bladder conservation by transurethral surgery, upfront MCV (methotrexate, cisplatin, and vinblastine) chemotherapy and pelvic irradiation plus cisplatin.
Marks LB; Kaufman SD; Prout GR; Heney NM; Griffin PP; Shipley WU
Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):877-83. PubMed ID: 3182328
[TBL] [Abstract][Full Text] [Related]
16. Upper urinary tract involvement after cystectomy and ileal conduit diversion for primary bladder carcinoma.
Tsuji Y; Nakamura H; Ariyoshi A
Eur Urol; 1996; 29(2):216-20. PubMed ID: 8647150
[TBL] [Abstract][Full Text] [Related]
17. Organ conservation in deeply invasive bladder cancer.
Fair WR
Prog Clin Biol Res; 1991; 370():119-26. PubMed ID: 1924440
[No Abstract] [Full Text] [Related]
18. RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.
Hagan MP; Winter KA; Kaufman DS; Wajsman Z; Zietman AL; Heney NM; Toonkel LM; Jones CU; Roberts JD; Shipley WU
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):665-72. PubMed ID: 14529770
[TBL] [Abstract][Full Text] [Related]
19. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
20. Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy.
Sternberg CN; Yagoda A; Scher HI; Whitmore WF; Herr HW; Morse MJ; Sogani PC; Bosl G; Watson RC; Hollander PS
Prog Clin Biol Res; 1988; 260():551-5. PubMed ID: 3283770
[No Abstract] [Full Text] [Related]
[Next] [New Search]
